Epigenetic changes in the progression of Alzheimer's disease

Mechanisms of Ageing and Development

Volumn 134, Issue 10, 2013, Pages 486-495

  Bradley Whitman, M A ^a   Lovell, M A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

5 Hydroxymethylcytosine; 5 Methylcytosine; Alzheimer's disease; Preclinical Alzheimer's disease

Indexed keywords

CELL NUCLEUS DNA; DNA; MITOCHONDRIAL DNA;

ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DISEASE COURSE; DNA METHYLATION; EPIGENETICS; FEMALE; GENE TRANSLOCATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; MALE; PARAHIPPOCAMPAL GYRUS; PATHOGENESIS; PRIORITY JOURNAL; SYMPTOMATOLOGY;

5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; ALZHEIMER'S DISEASE; PRECLINICAL ALZHEIMER'S DISEASE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBELLUM; EPIGENESIS, GENETIC; FEMALE; HIPPOCAMPUS; HUMANS; MALE; NERVE TISSUE PROTEINS; PARAHIPPOCAMPAL GYRUS;

EID: 84888133742     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2013.08.005     Document Type: Article

References (76)

1. Addya K., Wang Y.L., Leonard D.G. Optimization of apolipoprotein E genotyping. Mol. Diagn. 1997, 2:271-276.
2. Aluise C.D., Robinson R.A., Beckett T.L., Murphy M.P., Cai J., Pierce W.M., Markesbery W.R., Butterfield D.A. Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiol. Dis. 2010, 39:221-228.
3. Bakulski K.M., Dolinoy D.C., Sartor M.A., Paulson H.L., Konen J.R., Lieberman A.P., Albin R.L., Hu H., Rozek L.S. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J. Alzheimers Dis. 2012, 29:571-588.
4. Bhutani N., Brady J.J., Damian M., Sacco A., Corbel S.Y., Blau H.M. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010, 463:1042-1047.
5. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16:6-21.
6. Boorstein R.J., Cummings A., Marenstein D.R., Chan M.K., Ma Y., Neubert T.A., Brown S.M., Teebor G.W. Definitive identification of mammalian 5-hydroxymethyluracil DNA N-glycosylase activity as SMUG1. J. Biol. Chem. 2001, 276:41991-41997.
7. Bradley M.A., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med 2010, 48:1570-1576.
8. Bradley M.A., Xiong-Fister S., Markesbery W.R., Lovell M.A. Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression. Neurobiol. Aging 2012, 33:1034-1044.
9. Castro G.D., Diaz Gomez M.I., Castro J.A. 5-Methylcytosine attack by hydroxyl free radicals and during carbon tetrachloride promoted liver microsomal lipid peroxidation: structure of reaction products. Chem. Biol. Interact. 1996, 99:289-299.
10. Chromczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
11. Dunckley T., Beach T.G., Ramsey K.E., Grover A., Mastroeni D., Walker D.G., LaFleur B.J., Coon K.D., Brown K.M., Caselli R., Kukull W., Higdon R., McKeel D., Morris J.C., Hulette C., Schmechel D., Reiman E.M., Rogers J., Stephan D.A. Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiol. Aging 2006, 27:1359-1371.
12. Dzitoyeva S., Chen H., Manev H. Effect of aging on 5-hydroxymethylcytosine in brain mitochondria. Neurobiol. Aging 2012, 33:2881-2891.
13. Feng J., Zhou Y., Campbell S.L., Le T., Li E., Sweatt J.D., Silva A.J., Fan G. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat. Neurosci. 2010, 13:423-430.
14. Ficz G., Branco M.R., Seisenberger S., Santos F., Krueger F., Hore T.A., Marques C.J., Andrews S., Reik W. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011, 473:398-402.
15. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., Heine-Suner D., Cigudosa J.C., Urioste M., Benitez J., Boix-Chornet M., Sanchez-Aguilera A., Ling C., Carlsson E., Poulsen P., Vaag A., Stephan Z., Spector T.D., Wu Y.Z., Plass C., Esteller M. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10604-10609.
16. Fuso A., Seminara L., Cavallaro R.A., D'Anselmi F., Scarpa S. S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol. Cell. Neurosci. 2005, 28:195-204.
17. Gabbita S.P., Lovell M.A., Markesbery W.R. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 1998, 71:2034-2040.
18. Galvin J.E., Powlishta K.K., Wilkins K., McKeel D.W., Xiong C., Grant E., Storandt M., Morris J.C. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Arch. Neurol. 2005, 62:758-765.
19. Globisch D., Munzel M., Muller M., Michalakis S., Wagner M., Koch S., Bruckl T., Biel M., Carell T. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS ONE 2010, 5:e15367.
20. Guo J.U., Ma D.K., Mo H., Ball M.P., Jang M.H., Bonaguidi M.A., Balazer J.A., Eaves H.L., Xie B., Ford E., Zhang K., Ming G.L., Gao Y., Song H. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat. Neurosci. 2011, 14:1345-1351.
21. Haffner M.C., Chaux A., Meeker A.K., Esopi D.M., Gerber J., Pellakuru L.G., Toubaji A., Argani P., Iacobuzio-Donahue C., Nelson W.G., Netto G.J., De Marzo A.M., Yegnasubramanian S. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2011, 2:627-637.
22. Hajkova P., Ancelin K., Waldmann T., Lacoste N., Lange U.C., Cesari F., Lee C., Almouzni G., Schneider R., Surani M.A. Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 2008, 452:877-881.
23. Hajkova P., Erhardt S., Lane N., Haaf T., El-Maarri O., Reik W., Walter J., Surani M.A. Epigenetic reprogramming in mouse primordial germ cells. Mech. Dev. 2002, 117:15-23.
24. Hajkova P., Jeffries S.J., Lee C., Miller N., Jackson S.P., Surani M.A. Genome-wide reprogramming in the mouse germ line entails the base excision repair pathway. Science 2010, 329:78-82.
25. He Y.F., Li B.Z., Li Z., Liu P., Wang Y., Tang Q., Ding J., Jia Y., Chen Z., Li L., Sun Y., Li X., Dai Q., Song C.X., Zhang K., He C., Xu G.L. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 333:1303-1307.
26. Hyman B.T., Phelps C.H., Beach T.G., Bigio E.H., Cairns N.J., Carrillo M.C., Dickson D.W., Duyckaerts C., Frosch M.P., Masliah E., Mirra S.S., Nelson P.T., Schneider J.A., Thal D.R., Thies B., Trojanowski J.Q., Vinters H.V., Montine T.J. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 2012, 8:1-13.
27. Iqbal K., Jin S.G., Pfeifer G.P., Szabo P.E. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:3642-3647.
28. Ito S., D'Alessio A.C., Taranova O.V., Hong K., Sowers L.C., Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010, 466:1129-1133.
29. Ito S., Shen L., Dai Q., Wu S.C., Collins L.B., Swenberg J.A., He C., Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
30. Iwamoto K., Bundo M., Ueda J., Oldham M.C., Ukai W., Hashimoto E., Saito T., Geschwind D.H., Kato T. Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res. 2011, 21:688-696.
31. Iyer L.M., Tahiliani M., Rao A., Aravind L. Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle 2009, 8:1698-1710.
32. Jin S.G., Wu X., Li A.X., Pfeifer G.P. Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res. 2011, 39:5015-5024.
33. Koh K.P., Yabuuchi A., Rao S., Huang Y., Cunniff K., Nardone J., Laiho A., Tahiliani M., Sommer C.A., Mostoslavsky G., Lahesmaa R., Orkin S.H., Rodig S.J., Daley G.Q., Rao A. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011, 8:200-213.
34. Levenson J.M., Roth T.L., Lubin F.D., Miller C.A., Huang I.C., Desai P., Malone L.M., Sweatt J.D. Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J. Biol. Chem. 2006, 281:15763-15773.
35. Li W., Liu M. Distribution of 5-hydroxymethylcytosine in different human tissues. J Nucleic Acids 2011, 2011:870726.
36. Liang W.S., Dunckley T., Beach T.G., Grover A., Mastroeni D., Ramsey K., Caselli R.J., Kukull W.A., McKeel D., Morris J.C., Hulette C.M., Schmechel D., Reiman E.M., Rogers J., Stephan D.A. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol. Genomics 2008, 33:240-256.
37. Loft S., Hogh Danielsen P., Mikkelsen L., Risom L., Forchhammer L., Moller P. Biomarkers of oxidative damage to DNA and repair. Biochem. Soc. Trans. 2008, 36:1071-1076.
38. Lovell M.A., Gabbita S.P., Markesbery W.R. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J. Neurochem. 1999, 72:771-776.
39. Lovell M.A., Soman S., Bradley M.A. Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mech. Ageing Dev. 2011, 132:443-448.
40. Lubin F.D., Roth T.L., Sweatt J.D. Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J. Neurosci. 2008, 28:10576-10586.
41. Maiti A., Drohat A.C. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J. Biol. Chem. 2011, 286:35334-35338.
42. Mastroeni D., Grover A., Delvaux E., Whiteside C., Coleman P.D., Rogers J. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol. Aging 2010, 31:2025-2037.
43. Mastroeni D., McKee A., Grover A., Rogers J., Coleman P.D. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS ONE 2009, 4:e6617.
44. Mecocci P., MacGarvey U., Kaufman A.E., Koontz D., Shoffner J.M., Wallace D.C., Beal M.F. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brian. Am. Neurol. Assoc. 1993, 34:609-615.
45. Miller C.A., Gavin C.F., White J.A., Parrish R.R., Honasoge A., Yancey C.R., Rivera I.M., Rubio M.D., Rumbaugh G., Sweatt J.D. Cortical DNA methylation maintains remote memory. Nat. Neurosci. 2010, 13:664-666.
46. Miller C.A., Sweatt J.D. Covalent modification of DNA regulates memory formation. Neuron 2007, 53:857-869.
47. Moreira P.I., Nunomura A., Nakamura M., Takeda A., Shenk J.C., Aliev G., Smith M.A., Perry G. Nucleic acid oxidation in Alzheimer disease. Free Radic. Biol. Med. 2008, 44:1493-1505.
48. Mulder C., Schoonenboom N.S., Jansen E.E., Verhoeven N.M., van Kamp G.J., Jakobs C., Scheltens P. The transmethylation cycle in the brain of Alzheimer patients. Neurosci. Lett. 2005, 386:69-71.
49. Munzel M., Globisch D., Bruckl T., Wagner M., Welzmiller V., Michalakis S., Muller M., Biel M., Carell T. Quantification of the sixth DNA base hydroxymethylcytosine in the brain. Angew. Chem. Int. Ed. Engl. 2010, 49:5375-5377.
50. Nestor C.E., Ottaviano R., Reddington J., Sproul D., Reinhardt D., Dunican D., Katz E., Dixon J.M., Harrison D.J., Meehan R.R. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res. 2012, 22:467-477.
51. Nunomura A., Tamaoki T., Motohashi N., Nakamura M., McKeel D.W., Tabaton M., Lee H.G., Smith M.A., Perry G., Zhu X. The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons. J. Neuropathol. Exp. Neurol. 2012, 71:233-241.
52. Pastor W.A., Pape U.J., Huang Y., Henderson H.R., Lister R., Ko M., McLoughlin E.M., Brudno Y., Mahapatra S., Kapranov P., Tahiliani M., Daley G.Q., Liu X.S., Ecker J.R., Milos P.M., Agarwal S., Rao A. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 2011, 473:394-397.
53. Pfaffeneder T., Hackner B., Truss M., Munzel M., Muller M., Deiml C.A., Hagemeier C., Carell T. The discovery of 5-formylcytosine in embryonic stem cell DNA. Angew. Chem. Int. Ed. Engl. 2011, 50:7008-7012.
54. Robertson J., Robertson A.B., Klungland A. The presence of 5-hydroxymethylcytosine at the gene promoter and not in the gene body negatively regulates gene expression. Biochem. Biophys. Res. Commun. 2011, 411:40-43.
55. Saiki R.K., Bugawan T.L., Horn G.T., Mukkis K.B., Erlich H.A. Analysis of enzymatically amplified beta-globin and hla-dq alpha DNA with allele-specific olgionucleotide probes. Nature 1986, 324:163-166.
56. Scarpa S., Fuso A., D'Anselmi F., Cavallaro R.A. Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease?. FEBS Lett. 2003, 541:145-148.
57. Schmitt F.A., Davis D.G., Wekstein D.R., Smith C.D., Ashford J.W., Markesbery W.R. "Preclincal" AD revisited: neuropathology of cognitively older adults. Neurology 2000, 55:370-376.
58. Schwob N.G., Nalbantoglu J., Hastings K.E., Mikkelsen T., Cashman N.R. DNA cytosine methylation in brain of patients with Alzheimer's disease. Ann. Neurol. 1990, 28:91-94.
59. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 2002, 346:476-483.
60. Siegmund K.D., Connor C.M., Campan M., Long T.I., Weisenberger D.J., Biniszkiewicz D., Jaenisch R., Laird P.W., Akbarian S. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2007, 2:e895.
61. Sims N.R., Anderson M.F. Isolation of mitochondria from rat brain using Percoll density gradient centrifugation. Nat. Protoc. 2008, 3:1228-1238.
62. Smith C.D., Chebrolu H., Markesbery W.R., Liu J. Improved predictive model for pre-symptomatic mild cognitive impairment and Alzheimer's disease. Neurol. Res. 2008, 30:1091-1096.
63. Song C.X., Szulwach K.E., Fu Y., Dai Q., Yi C., Li X., Li Y., Chen C.H., Zhang W., Jian X., Wang J., Zhang L., Looney T.J., Zhang B., Godley L.A., Hicks L.M., Lahn B.T., Jin P., He C. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 2011, 29:68-72.
64. Stroud H., Feng S., Morey Kinney S., Pradhan S., Jacobsen S.E. 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol. 2011, 12:R54.
65. Suzuki M.M., Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 2008, 9:465-476.
66. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer L.M., Liu D.R., Aravind L., Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
67. Timmons M.D., Bradley M.A., Lovell M.A., Lynn B.C. Procedure for the isolation of mitochondria, cytosolic and nuclear material from a single piece of neurological tissue for high-throughput mass spectral analysis. J. Neurosci. Methods 2011, 197:279-282.
68. Tohgi H., Utsugisawa K., Nagane Y., Yoshimura M., Genda Y., Ukitsu M. Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex. Brain Res. Mol. Brain Res. 1999, 70:288-292.
69. Tsukamoto K., Watanabe T., Matsushima T., Kinoshita M., Kato H., Hashimoto Y., Kurokawa K., Teramoto T. Determination by PCR-RFLP of apo E genotype in a Japanese population. J. Lab. Clin. Med. 1993, 121:598-602.
70. Valinluck V., Tsai H.H., Rogstad D.K., Burdzy A., Bird A., Sowers L.C. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 2004, 32:4100-4108.
71. Wang J., Markesbery W.R., Lovell M.A. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J. Neurochem. 2006, 96:825-832.
72. Wang S.C., Oelze B., Schumacher A. Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS ONE 2008, 3:e2698.
73. Weitzman S.A., Turk P.W., Milkowski D.H., Kozlowski K. Free radical adducts induce alterations in DNA cytosine methylation. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:1261-1264.
74. West R.L., Lee J.M., Maroun L.E. Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient. J. Mol. Neurosci. 1995, 6:141-146.
75. Wu H., D'Alessio A.C., Ito S., Wang Z., Cui K., Zhao K., Sun Y.E., Zhang Y. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev. 2011, 25:679-684.
76. Wu H., Zhang Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev. 2011, 25:2436-2452.